Lactone stable formulation of camptothecin and methods for uses thereof
US5597829A · kind A · utility
12Cited by
21References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 1994 |
| Grant date | Jan 28, 1997 |
| Priority date | — |
| Expiry date | May 9, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1075
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Camptothecin (CPT) an anticancer drug is poorly soluble in water. This invention overcomes this limitation by teaching novel pharmaceutically acceptable lactone stable CPT formulations for the direct administration of CPT to human subjects with cancer. The claimed invention also describes novel dosages, schedules, and routes of administration of the lactone stable CPT formulations to patients with various forms of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.